Friday, March 20, 2009

Day #253 - Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis:

There are few treatment options aside from lung transplantation, which actually substitutes one chronic disease for another. A review is available here.
We discussed the concept of "acute exacerbation" of IPF -- a review of this condition and the treatment is here. The mortality is approximately 60-70% at 3 months.
Like many diseases, exercise programs can be helpful in improving functional status.

Thursday, March 19, 2009

Day #252 - Infective Endocarditis (Staphylococcus Aureus)

Today we heard a case of a patient with a known history of injection drug use who presented with multiple swollen joints, in the context of a persistant staphylococcal bacteremia. The patient also had a history of previous endocarditis and on exam had evidence of moderate-severe tricuspid regurgitation.

I have reviewed the diagnostic criteria for endocarditis here.

I have previously blogged about staphyloccocal bacteremia here. I will re-iterate that for methicillin sensitive staph aureus vancomycin is INFERIOR to beta-lactam therapy.

Some newer evidence suggests that the risk of using adjuvant gentamicin in native valve staphylococcal bacteremia/endocarditis is greater than the benefit.

An interesting concept, which I am now going to endorse because it is inexpensive and relatively simple, is continuous cloxacillin infusion as opposed to intermittant infusion. In this study the 30 day microbiologic cure was 94% in the CI group as opposed to 79% in the II group (ARR 15%, NNT 8).

There have been several studies looking at treatment options in injection drug users. Long term antibiotic therapy requires indwelling lines and this usually mandates extended hospitalization or "confinement" if ongoing drug use is a concern. These two studies (larger study, smaller study) have evaluated quinolone (ciprofloxacin, though today levofloxacin or moxifloxacin would likely be even more effective) combined with rifampin in right sided IE. These are small studies, so they shouldn't influence practice in general -- but in certain cases may be the only option.

Wednesday, March 18, 2009

Day #251 - DVT (Phlegmasia Cerulea Dolens)


Today we heard a case of a patient who presented with an acute, cold/blue, painful leg. The cause of this was identified as a mixture of a large DVT on a background of peripheral vascular disease.

In phledmasia cerulea dolens (see right, from NEJM) the DVT, usually very large, causes venous outflow obstruction which, in turn, leads to elevated tissue pressures which can significantly reduce arterial flow leading to tissue ischemia.

In today's patient they presented with a lactic acidosis probably related to tissue hypoxemia.

There are a number of interesting articles about interventional and surgical approaches to the treatment of massive DVT causing PCD. The goal of therapy is to salvage the limb before it becomes gangrenous. This article discusses manual clot aspiration. This is a more complete review of the interventional options.

Note: in our case, thrombolysis was contraindicated because of the recent large ischemic stroke.

My colleague at TWH has posted a summary of the "Wells Criteria" for the clinical diagnosis of DVT.

Using this algorithm, a low risk patient with a negative D-dimer does not have a DVT. A high risk patient, or one with a positive D-dimer will require further investigation.

Duplex Compression Doppler Ultrasound is usually the test of choice. Treatment involves anticoagulation with heparin (unfractionated or low molecular weight depending on clinical scenario -- usually LMWH) which is generally followed by coumadin after 2 days of anticoagulation with overlap until INR 2-3 x 2 days and a minimum of 5 days of heparin

Tuesday, March 17, 2009

Day #250 - Safe Patient Signover

Today was a special session on safe signover practices. Signover/Signout/Handover of care between physicians (particularly at teaching hospitals) is one of the most dangerous times. By paying attention to the process, we can improve the quality of signover and hopefully provide safer and more efficient cross-coverage.

The presenters referenced these articles:

Monday, March 16, 2009

Day #249 - ITP

Today we heard the case of a patient with severe thrombocytopenia, presumed ITP (bone marrow biopsy pending)

I have previously blogged about thrombocytopenia here.

Thursday, March 12, 2009

Day #245 - (Cryptogenic) Organizing Pneumonia

Today we talked about a case of a patient with organizing pneumonia in the context of advanced rheumatoid arthritis on penicillamine.

The discussant reviewed the respiratory complications from RA:
  • Pulmonary nodules
  • Pleural effusion
  • Pulmonary Fibrosis
  • Bronchiolitis Obliterans
  • Organizing pneumonia
  • Cavitary disease -- with pneumoconiaosis (Caplan's syndrome)
  • Related to immunosuppression (i.e. methotrexate lung)
We then discussed the diagnosis and management of organizing pneumonia in rheumatoid arthritis.

Wednesday, March 11, 2009

Day #244 - Pulmonary Embolism in CML

I have discussed PE/DVT before here (diagnosis, management)

There is a good taxonomy of the myeloproliferative disorders and leukemias here. Another (less detailed but more readable) review is available here.

A specific review of thrombocytosis and its management (which this patient has) is available here.

The NEJM has an article on the initial treatment of CML (which I suspect this patient has).